Telo Genomics Corp Stock Buy Hold or Sell Recommendation
| TELO Stock | CAD 0.12 0.01 9.09% |
Assuming the 90 days trading horizon and your above-average risk tolerance, our recommendation regarding Telo Genomics Corp is 'Strong Sell'. A buy or sell recommendation is an automated directive regarding whether to purchase or sell Telo Genomics Corp given historical horizon and risk tolerance. When we issue a 'buy' or 'sell' recommendation for Telo Genomics Corp, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Telo Genomics Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as Telo and provide practical buy, sell, or hold advice based on investors' constraints. Telo Genomics Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
Telo |
Execute Telo Genomics Buy or Sell Advice
The Telo recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Telo Genomics Corp. Macroaxis does not own or have any residual interests in Telo Genomics Corp or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Telo Genomics' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Out of control | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Quite High | Details | |
Economic Sensitivity | Moves slightly opposite to the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Telo Genomics Trading Alerts and Improvement Suggestions
| Telo Genomics Corp generated a negative expected return over the last 90 days | |
| Telo Genomics Corp has high historical volatility and very poor performance | |
| Telo Genomics Corp has some characteristics of a very speculative penny stock | |
| Telo Genomics Corp has high likelihood to experience some financial distress in the next 2 years | |
| Telo Genomics Corp has accumulated 32.5 K in total debt. Telo Genomics Corp has a current ratio of 0.09, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Telo Genomics until it has trouble settling it off, either with new capital or with free cash flow. So, Telo Genomics' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Telo Genomics Corp sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Telo to invest in growth at high rates of return. When we think about Telo Genomics' use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (2.82 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Telo Genomics Corp has accumulated about 24.25 K in cash with (2.63 M) of positive cash flow from operations. | |
| Latest headline from news.google.com: Oracle Corp Quote - Press Release - The Globe and Mail |
Telo Genomics Returns Distribution Density
The distribution of Telo Genomics' historical returns is an attempt to chart the uncertainty of Telo Genomics' future price movements. The chart of the probability distribution of Telo Genomics daily returns describes the distribution of returns around its average expected value. We use Telo Genomics Corp price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Telo Genomics returns is essential to provide solid investment advice for Telo Genomics.
| Mean Return | -0.24 | Value At Risk | -12.5 | Potential Upside | 15.38 | Standard Deviation | 7.82 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Telo Genomics historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Telo Genomics Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | 901.5K | 2.7M | (943.5K) | (19.7K) | (22.7K) | (21.5K) | |
| Free Cash Flow | (1.1M) | (1.1M) | (1.8M) | (2.7M) | (2.4M) | (2.6M) | |
| Net Income | (1.2M) | (1.1M) | (2.1M) | (2.8M) | (2.5M) | (2.7M) | |
| End Period Cash Flow | 921.0K | 3.6M | 2.7M | 2.7M | 3.1M | 3.2M | |
| Depreciation | 64.7K | 62.2K | 57.0K | 33.1K | 29.8K | 53.5K | |
| Change To Netincome | 343.4K | 263.8K | (45.7K) | 151.4K | 136.3K | 129.5K | |
| Investments | (8.7K) | (9.3K) | (25.2K) | (69.1K) | (79.4K) | (83.4K) | |
| Other Non Cash Items | (95.7K) | (183.5K) | 206.6K | 252.2K | 227.0K | 274.4K |
Telo Genomics Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Telo Genomics or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Telo Genomics' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Telo stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.28 | |
β | Beta against Dow Jones | 0.57 | |
σ | Overall volatility | 7.97 | |
Ir | Information ratio | -0.04 |
Telo Genomics Volatility Alert
Telo Genomics Corp is displaying above-average volatility over the selected time horizon. Telo Genomics Corp is a potential penny stock. Although Telo Genomics may be in fact a good instrument to invest, many penny stocks are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in Telo Genomics Corp. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Telo instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Telo Genomics Fundamentals Vs Peers
Comparing Telo Genomics' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Telo Genomics' direct or indirect competition across all of the common fundamentals between Telo Genomics and the related equities. This way, we can detect undervalued stocks with similar characteristics as Telo Genomics or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Telo Genomics' fundamental indicators could also be used in its relative valuation, which is a method of valuing Telo Genomics by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Telo Genomics to competition |
| Fundamentals | Telo Genomics | Peer Average |
| Return On Equity | -1.69 | -0.31 |
| Return On Asset | -0.87 | -0.14 |
| Current Valuation | 6.94 M | 16.62 B |
| Shares Outstanding | 74.56 M | 571.82 M |
| Shares Owned By Insiders | 5.34 % | 10.09 % |
| Shares Owned By Institutions | 2.74 % | 39.21 % |
| Number Of Shares Shorted | 2.46 K | 4.71 M |
| Price To Book | 220.96 X | 9.51 X |
| EBITDA | (2.79 M) | 3.9 B |
| Net Income | (2.82 M) | 570.98 M |
| Cash And Equivalents | 24.25 K | 2.7 B |
| Total Debt | 32.5 K | 5.32 B |
| Current Ratio | 0.09 X | 2.16 X |
| Book Value Per Share | 0.01 X | 1.93 K |
| Cash Flow From Operations | (2.63 M) | 971.22 M |
| Short Ratio | 0.07 X | 4.00 X |
| Earnings Per Share | (0.04) X | 3.12 X |
| Beta | 1.04 | -0.15 |
| Market Capitalization | 8.57 M | 19.03 B |
| Total Asset | 2.93 M | 29.47 B |
| Retained Earnings | (25.12 M) | 9.33 B |
| Working Capital | 2.56 M | 1.48 B |
| Net Asset | 2.93 M |
Telo Genomics Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Telo . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Daily Balance Of Power | 9.2 T | |||
| Rate Of Daily Change | 1.09 | |||
| Day Median Price | 0.12 | |||
| Day Typical Price | 0.12 | |||
| Price Action Indicator | 0.005 | |||
| Period Momentum Indicator | 0.01 |
About Telo Genomics Buy or Sell Advice
When is the right time to buy or sell Telo Genomics Corp? Buying financial instruments such as Telo Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Telo Genomics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Utilities - Regulated Electric Thematic Idea Now
Utilities - Regulated Electric
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Utilities - Regulated Electric theme has 7 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Utilities - Regulated Electric Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Telo Stock Analysis
When running Telo Genomics' price analysis, check to measure Telo Genomics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Telo Genomics is operating at the current time. Most of Telo Genomics' value examination focuses on studying past and present price action to predict the probability of Telo Genomics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Telo Genomics' price. Additionally, you may evaluate how the addition of Telo Genomics to your portfolios can decrease your overall portfolio volatility.